Liposomal Amphotericin B (AmBisome) in the Treatment of Neonatal Candidiasis in Very Low Birth Weight Infants

Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases

Eric H. Kossoff, E. Stephen Buescher, M. Gary Karlowicz · The Pediatric Infectious Disease Journal · 1998 · 335 citations

Disseminated Fungal Infections in Very Low-Birth-Weight Infants: Clinical Manifestations and Epidemiology

Jill E. Baley, Robert M. Kliegman, Avroy A. Fanaroff · PEDIATRICS · 1984 · 277 citations

Diagnostic Mycology, Neonatology, Antibiotics +14

Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial

F. Meunier, H. G. Prentice, Olle Ringdén · Journal of Antimicrobial Chemotherapy · 1991 · 245 citations

Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams).

Dana E. Johnson, Theodore R. Thompson, Thomas P. Green et al. · PubMed · 1984 · 174 citations

Neonatology, Clinical Mycology, Premature Infants +16

Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single‐centre experience of 133 episodes in 116 patients

Wendy Mills, Rajesh Chopra, David C. Linch et al. · British Journal of Haematology · 1994 · 172 citations